This site is intended for healthcare professionals only
LoginRegister
Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boomEli Lilly bowel disease drug Mirikizumab rejected by USFDA
R21 Vaccine Not for India Yet, Government Informs ParliamentUniversity of Oxford Malaria vaccine gets regulatory clearance for use in Ghana
Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell CarcinomaUSFDA accepts application for Merck KEYTRUDA plus Chemotherapy as first line treatment for Locally...
Takeda gets USFDA nod to expand use of HYQVIA to treat primary immunodeficiency in childrenTakeda gets USFDA nod to expand use of HYQVIA to treat primary immunodeficiency in children
Mansukh Mandaviya to hold meeting with e-pharmacies representatives soonMansukh Mandaviya to hold meeting with e-pharmacies representatives soon
Serum Institute Gets NPPA Nod to Discontinue Two Pack Sizes of Tetanus Toxoid VaccineRise in COVID cases: Serum Institute restarts manufacturing of Covishield
Parliamentary Panel Slams CDSCO for Slow Drug Approvals, Calls for Conditional Licensing in 45 DaysCDSCO seeks details of 16 FDCs named as irrational for further examination
Glenmarks Telma Surpasses Rs 1,000 Crore Revenue, Recognized in Harvard Case StudyGlenmark Pharma weighs selling stake in Glenmark Lifesciences
Riad Mishlawi to become CEO of Hikma PharmaRiad Mishlawi to become CEO of Hikma Pharma
Boehringer Ingelheim, AnGes sign manufacturing agreement for HGF gene therapy productBoehringer Ingelheim, Cognizant ink pact on Unified Cloud Platform to speed delivery of life saving...
IPM grew 19 percent in March, brands like Calpol, Augmentin observed highest growth: IQVIAIPM grew 19 percent in March, brands like Calpol, Augmentin observed highest growth: IQVIA
Lupin Nagpur facility completes USFDA inspectionLupin Diagnostics unveils Regional Reference Laboratory in Bengaluru
X